-
1 week ago | 
news.bloombergtax.com | Lin Cheng
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
1 week ago | 
news.bloomberglaw.com | Lin Cheng
Aventiv Technologies says it agreed with financial sponsor Platinum Equity and supporting lenders to recapitalize business via debt-for-equity exchange.
-
2 weeks ago | 
news.bloomberglaw.com | Lin Cheng
(Adds share move.)Pacira BioSciences shares rise 18% postmarket after the company said it had settled litigations with Fresenius Kabi USA, Jiangsu Hengrui Pharmaceuticals and eVenus Pharmaceuticals Laboratories related to patents for Exparel.
-
3 weeks ago | 
news.bloomberglaw.com | Lin Cheng
The Office of the Comptroller of the Currency (OCC) withdrew its participation in the interagency principles for climate-related financial risk management for large financial institutions. “The principles providing guidance to banks for climate-related financial risk are overly burdensome and duplicative, ” Acting Comptroller of the Currency Rodney E.
-
3 weeks ago | 
news.bloombergtax.com | Lin Cheng
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
3 weeks ago | 00053-2&sz=64)
cell.com | Lin Cheng |Yanglu Wang |Jingyang Guan |Hongkui Deng
Keywordschemical reprogrammingsmall moleculeshuman chemically induced pluripotent stem cells (hCiPSCs)plasticitypluripotencyregenerationGet full text accessLog in, subscribe or purchase for full access. References1. Gurdon, J.B.The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpolesJ. Embryol. Exp. Morpholog. 1962; 10:622-6402. Takahashi, K. ∙ Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factorsCell.
-
4 weeks ago | 
news.bloombergtax.com | Lin Cheng
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
4 weeks ago | 
news.bloomberglaw.com | Lin Cheng
China Evergrande New Energy Vehicle Group says it has noted recent increase in its stock price and trading volume, and confirms it’s not aware of any reason, according to Hong Kong stock exchange filing.
-
4 weeks ago | 
biorxiv.org | Jessica Chan |A Thomas Read |Guorong Li |Lin Cheng
AbstractTrabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells).
-
1 month ago | 
news.bloombergtax.com | Lin Cheng
Dun & Bradstreet agreed to be acquired by Clearlake Capital for $9.15/share in cash in transaction at equity value of $4.1 billion.
